[Form 4] Enova International, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Enova International insider transactions by CEO/Director David Fisher: The filing shows Mr. Fisher exercised employee stock options and simultaneously sold portions of his shares on August 28-29, 2025. He exercised a total of 25,000 options at an exercise price of $23.96 per share (15,000 on 08/28/2025 and 10,000 on 08/29/2025), increasing beneficial ownership represented by the exercised shares before sales to 363,223 and then 358,223 shares as sales occurred. On the same dates he sold 25,000 shares (15,000 and 10,000) at weighted-average prices of $121.8028 and $121.7989 respectively (execution ranges disclosed in the filing). Post-transactions his direct beneficial ownership is reported as 348,223 shares. The exercised options are non-qualified options with corresponding limited SARs that vest in prior years and expire February 12, 2026. The filing was signed by an attorney-in-fact on September 2, 2025.

Positive

• Exercise of vested options indicates management is receiving long-term compensation that vests over time
• Clear disclosure of execution price ranges and weighted-average sale prices improves transparency

Negative

• Substantial insider sales of 25,000 shares at weighted-average prices near $121.80 reduced the reporting person’s direct holdings to 348,223 shares
• Options expire February 12, 2026, limiting future optionality for the reported grants

Insights

Corporate Governance Expert

TL;DR: CEO exercised vested options then sold the resulting shares; routine compensation-related liquidity, not necessarily signaling company fundamentals.

The pattern—exercise of vested non-qualified options followed by sales—matches common executive behavior to cover tax liabilities or diversify holdings after vesting. The filing discloses precise exercise prices ($23.96) and weighted-average sale prices (~$121.80) with execution ranges provided for transparency. The presence of limited SARs paired with options is noted; these SARs only become exercisable on specified corporate change events and do not affect current liquidity. This is a standard Section 16 disclosure; absent other context (e.g., sizable additional insider sales or material corporate events), the transactions appear administrative rather than tied to new information about operations.

Securities Analyst

TL;DR: Materiality is limited—transactions are sizable in nominal dollars but are option-driven and individually routine.

The filing reports the exercise of 25,000 options and concurrent disposition of 25,000 shares at ~ $121.80, which realized substantial proceeds relative to exercise cost ($23.96). Post-transaction direct ownership stands at 348,223 shares. From an investor-impact perspective, these trades are disclosed as required and lack accompanying operational or financial disclosures that would elevate their significance. Investors seeking material signal should compare these trades to historical insider activity and aggregate holdings; this filing alone is neutral in impact.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fisher David

(Last) (First) (Middle)

C/O ENOVA INTERNATIONAL, INC.

175 W. JACKSON BOULEVARD, SUITE 600

(Street)

CHICAGO IL 60604

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enova International, Inc. [ ENVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.00001 per share	08/28/2025		M		15,000	A	$23.96	363,223	D
Common stock, par value $0.00001 per share	08/28/2025		S		15,000	D	$121.8028(1)	348,223	D
Common Stock, par value $0.00001 per share	08/29/2025		M		10,000	A	$23.96	358,223	D
Common Stock, par value $0.00001 per share	08/29/2025		S		10,000	D	$121.7989(2)	348,223	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy) with limited SAR(3)(4)	$23.96	08/28/2025		M			15,000	(5)	02/12/2026	Common stock; par value $0.00001 per share	15,000	$0	145,562	D
Non-Qualified Stock Option (right to buy) with limited SAR(3)(4)	$23.96	08/29/2025		M			10,000	(5)	02/12/2026	Common stock; par value $0.00001 per share	10,000	$0	135,562	D

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $121.16 to $122.80. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.

2. This transaction was executed in multiple trades at prices ranging from $121.10 to $122.1638. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.

3. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

4. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

5. The options vested in substantially equal one-third increments on each of the following dates: February 12, 2020, February 12, 2021, and February 12, 2022.

	/s/ Sean Rahilly, as attorney in fact	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Enova (ENVA) CEO David Fisher report on Form 4?

The Form 4 reports Mr. Fisher exercised 25,000 non-qualified options (15,000 on 08/28/2025 and 10,000 on 08/29/2025 at $23.96) and sold 25,000 shares the same dates.

At what prices were the ENVA shares sold by the reporting person?

Sales were reported at weighted-average prices of $121.8028 (08/28/2025) and $121.7989 (08/29/2025) with execution ranges disclosed in the filing.

How many ENVA shares does David Fisher beneficially own after these transactions?

Following the transactions, the filing reports Mr. Fisher's direct beneficial ownership as 348,223 shares.

Do the exercised options have related stock appreciation rights (SARs)?

Yes. The non-qualified options were granted in tandem with limited SARs; exercising one instrument results in expiration of the other and SARs are exercisable only upon a defined Change in Control or Offer.

When do the reported options expire?

The filing states the options expire on February 12, 2026.